BlackRock, Inc. 13D and 13G filings for Viracta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Viracta Therapeutics, Inc. VIRX | BlackRock Inc. BLK | 542,431 1.400% | -1,826,487 (-77.10%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Viracta Therapeutics, Inc. VIRX | BlackRock Inc. BLK | 2,368,918 6.300% | 2,368,918 (New Position) | Filing |